GO Therapeutics is committed to creating the next generation of cancer-specific antibody therapeutics.

GO is actively seeking strategic partnerships to advance high-potential product candidates. We are interested in building alliances that will enable us to realize our long-term vision of transforming lives with safer and more effective cancer therapies.
If you are interested in partnering with us, please contact Constantine Theodoropulos, Chief Executive Officer, GO Therapeutics.